362. Paul Coletta, Co-Founder & CEO of Vero Bioscience
Today, I'm joined by Paul Coletta, co-founder & CEO of Vero Bioscience.
A predictive health company, Vero uses proteomic blood tests and proprietary AI to measure and improve organ-level aging.
In this episode, we discuss building a closed-loop health system powered by proteomics.
We also cover:
Why organ-level data beats whole-body scores
How proteomics differs from other biological age measures
Reproducibility, clinical validation, and roadmap to launch
Subscribe to the podcast → insider.fitt.co/podcast
Subscribe to our newsletter → insider.fitt.co/subscribe
Follow us on LinkedIn →…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.